Amgen (AMGN) EBITDA (2009 - 2026)
Amgen (AMGN) posted EBITDA of $4.63 billion for Q2 2026, up 15.7% from $4 billion a year earlier and up 22.3% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) EBITDA (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Amgen was $16.09 billion, up 17.4% year-over-year; for FY2025, it came in at $14.25 billion, up 10.9% from FY2024.
- Annual EBITDA shows a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- In prior years, Amgen's EBITDA was $12.85 billion in FY2024 (+7.4%), $11.97 billion in FY2023 (-7.8%), $12.98 billion in FY2022 (+17.6%) and $11.04 billion in FY2021 (-13.4%).
- The Q2 2026 figure stands as the highest quarterly EBITDA in data going back to Q1 2009.
- On a year-over-year basis, EBITDA has increased in each of the last eight quarters, with growth averaging 20.6% over the last eight quarters.
- The strongest year-over-year quarter for EBITDA in the past five years was Q2 2022, with growth of 78.5%; the weakest was Q3 2023, with a decline of 16.6%.
- According to Business Quant data, EBITDA for the three prior quarters was $3.78 billion (Q1 2026), $3.85 billion (Q4 2025) and $3.83 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 782.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.83 Bn |
| Jun 30, 2026 | 4.63 Bn |
| Mar 31, 2026 | 3.78 Bn |
| Dec 31, 2025 | 3.85 Bn |
| Sep 30, 2025 | 3.83 Bn |
| Jun 30, 2025 | 4.00 Bn |
| Mar 31, 2025 | 2.57 Bn |
| Dec 31, 2024 | 3.71 Bn |
| Sep 30, 2024 | 3.44 Bn |
| Jun 30, 2024 | 3.31 Bn |
| Mar 31, 2024 | 2.39 Bn |
| Dec 31, 2023 | 2.65 Bn |
| Sep 30, 2023 | 2.92 Bn |
| Jun 30, 2023 | 3.58 Bn |
| Mar 31, 2023 | 2.82 Bn |
| Dec 31, 2022 | 3.14 Bn |
| Sep 30, 2022 | 3.50 Bn |
| Jun 30, 2022 | 3.00 Bn |
| Mar 31, 2022 | 3.34 Bn |
| Dec 31, 2021 | 3.16 Bn |
API Access
Amgen EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();